Establishing the Minimal Clinically Important Difference, Substantial Clinical Benefit, and Patient Acceptable Symptomatic State for Patient-Reported Outcome Measures After Primary Posterior Cruciate Ligament Reconstruction With a Minimum 5-Year Follow-up